register | login
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2022 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: Abiraterone Acetate

Significant tumour response to neoadjuvant therapy in high-risk non-metastatic prostate cancer

Presented By
Prof. Neil Fleshner, Princess Margaret Cancer Centre, Canada
Trial
Phase 2, ACDC-RP
Conference
ASCO GU 2022

8 April, 2022 11:22

Addition of abiraterone to ADT/docetaxel does not increase bone loss

Presented By
Dr Guilhem Roubaud, Institut Bergonié, France
Trial
Phase 3, PEACE-1
Conference
ASCO GU 2022

8 April, 2022 11:21

Both men with high-risk non-metastatic prostate cancer and men with metastatic prostate cancer benefit from intensified hormone treatment

Trial
Phase 3, PEACE-1, STAMPEDE, ARCHES
Conference
ESMO 2021

19 November, 2021 09:27

Radiographic PFS benefit of adding abiraterone to ADT and docetaxel in mCSPC

Presented By
Prof. Karim Fizazi, University of Paris-Saclay, Villejuif, France
Trial
Phase 3, PEACE-1
Conference
EAU 2021

31 August, 2021 12:15

Abiraterone added to ADT + docetaxel nearly doubles survival in de novo mCSPC

Presented By
Dr Karim Fizazi , Institut Gustav Roussy, France
Trial
Phase 3, PEACE-1
Conference
ASCO 2021

12 August, 2021 22:19

Apalutamide prolongs progression-free survival in prostate cancer

Presented By
Dr Dana Rathkopf, Memorial Sloan Kettering Cancer Center, New York, USA
Trial
Phase 3, ACIS
Conference
ASCO GU 2021

24 March, 2021 14:49

Abiraterone in M1 hormone-naïve prostate cancer

Conference
ESMO 2020

25 November, 2020 14:51

New treatment option for patients with mCRPC

Conference
ESMO 2020

25 November, 2020 14:50
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT